A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome

Immunity

Volumn 10, Issue 2, 1999, Pages 163-171

  Cressman, Drew E ^a   Chin, Keh Chuang ^a,b   Taxman, Debra J ^a   Ting, Jenny P y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BARE LYMPHOCYTE SYNDROME; CELLULAR DISTRIBUTION; DISEASE SEVERITY; GENE DELETION; IMMUNE DEFICIENCY; INTRACELLULAR TRANSPORT; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

EID: 0033082169     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80017-5     Document Type: Article

References (49)

1. Abdulkadir, S.A., and Ono, S.J. (1995). How are class II MHC genes turned on and off? FASEB J. 9, 1429-1435.
2. Accolla, R.S. (1983). Human B cell variants immunoselected against a single la antigen subset have lost expression of several la antigen subsets. J. Exp. Med. 157, 1053-1058.
3. Arens, M.Q., Knutsen, A.P., Schwarz, K.B., Roodman, ST., and Swierkosz, E.M. (1987). Multiple and persistent viral infections in a patient with bare lymphocyte syndrome. J. Infect. Dis. 156, 837-841.
4. Bonifaci, N., Moroianu, J., Radu, A., and Blobel, G. (1997). Karyopherin beta2 mediates nuclear import of a mRNA binding protein. Proc. Natl. Acad. Sci. USA. 94, 5055-5060.
5. Bontron, S., Steimle, V., Ucla, C., Eibl, M.M., and Mach, B. (1997). Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99, 541-546.
6. Boss, J.M. (1997). Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9, 107-113.
7. Brown, J.A., Rogers, E.M., and Boss, J.M. (1998). The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26, 4128-4136.
8. Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: A homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
9. Chang, C.H., and Flavell, R.A. (1995). Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181, 765-767.
10. Chang, C.H., Fontes, J.D., Peterlin, M., and Flavell, R.A. (1994). Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180, 1367-1374.
11. Chin, K.C., Li, G.G., and Ting, J.P. (1997). Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94, 2501-2506.
12. Cressman, D.E., Greenbaum, L.E., Deangelis, R.A., Ciliberto, G., Furth, E.E., Poli, V., and Taub, R. (1996). Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379-1383.
13. de Kok, Y.J., van der Maarel, S.M., Bitner-Glindzicz, M., Huber, I., Monaco, A.P., Malcolm, S., Pembrey, M.E., Ropers, H.H., and Cremers, F.P. (1995). Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science 267, 685-688.
14. de Preval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C., and Mach, B. (1985). A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318, 291-293.
15. Douhan, J.R., Hauber, I., Eibl, M.M., and Glimcher, L.H. (1996). Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains. J. Exp. Med. 183, 1063-1069.
16. Durand, B., Sperisen, P., Emery, P., Barras, E., Zufferey, M., Mach, B., and Reith, W. (1997). RFXAP, A novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16, 1045-1055.
17. Efthymiadis, A., Briggs, L.J., and Jans, D.A. (1998). The HIV-1 tat nuclear localization sequence confers novel nuclear import properties. J. Biol. Chem. 273, 1623-1628.
18. Fagotto, F., Gluck, U., and Gumbiner, B.M. (1998). Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr. Biol. 8, 181-190.
19. Gorlich, D., and Mattaj, I.W. (1996). Nucleocytoplasmic transport. Science 271, 1513-1518.
20. Hauber, I., Gulle, H., Wolf, H.M., Maris, M., Eggenbauer, H., and Eibl, M.M. (1995). Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. J. Exp. Med. 181, 1411-1423.
21. Hume, C.R., Shookster, L.A., Collins, N., O'Reilly, R., and Lee, J.S. (1989). Bare lymphocyte syndrome: Altered HLA class II expression in B cell lines derived from two patients. Hum. Immunol. 25, 1-11.
22. Jans, D.A., and Hubner, S. (1996). Regulation of protein transport to the nucleus: Central role of phosphorylation. Physiol. Rev. 76, 651-685.
23. Kara, C.J., and Glimcher, L.H. (1991). In vivo footprinting of MHC class II genes: Bare promoters in the bare lymphocyte syndrome. Science 252, 709-712.
24. Leonard, W.J., and O'Shea, J.J. (1998). Jaks and stats: Biological implications. Annu. Rev. Immunol. 16, 293-322.
25. Liou, H.C., and Baltimore, D. (1993). Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 5, 477-487.
26. Lisowska-Grospierre, B., Charron, D.J., de Preval, C., Durandy, A., Griscelli, C., and Mach, B. (1985). A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. Clin. Invest. 76, 381-385.
27. Mach, B., Steimle, V., Martinez-Soria, E., and Reith, W. (1996). Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14, 301-331.
28. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Jr., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., et al. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238.
29. Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.C., Hochstrasser, D.F., Mach, B., and Reith, W. (1998). A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20, 273-277.
30. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
31. Nadler, S.G., Tritschler, D., Haffar, O.K., Blake, J., Bruce, A.G., and Cleaveland, J.S. (1997). Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences. J. Biol. Chem. 272, 4310-4315.
32. Peijnenburg, A., Godthelp, B., van Boxel-Dezaire, A., and van den Elsen, P.J. (1995). Definition of a novel complementation group in MHC class II deficiency. Immunogenetics 41, 287-294.
33. Pfaffle, R.W., Dimattia, G.E., Parks, J.S., Brown, M.R., Wit, J.M., Jansen, M., Van der Nat, H., Van den Brande, J.L., Rosenfeld, M.G., and Ingraham, H.A. (1992). Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257, 1118-1121.
34. Piskurich, J.F., Wang, Y., Linhoff, M.W., White, L.C., and Ting, J.P. (1998). Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 160, 233-240.
35. Prieve, M.G., Guttridge, K.L., Munguia, J., and Waterman, M.L. (1998). Differential importin-alpha recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1. Mol. Cell. Biol. 18, 4819-4832.
36. Radovick, S., Nations, M., Du, Y., Berg, L.A., Weintraub, B.D., and Wondisford, F.E. (1992). A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257, 1115-1118.
37. Rao, A., Luo, C., and Hogan, P.G. (1997). Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 15, 707-747.
38. Reith, W., Steimle, V., and Mach, B. (1995). Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today. 16, 539-546.
39. Reith, W., Satola, S., Sanchez, C.H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M.R., and Mach, B. (1988). Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53, 897-906.
40. Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A., and Boss, J.M. (1995). Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2, 533-543.
41. Schlenstedt, G. (1996). Protein import into the nucleus. FEBS Lett. 389, 75-79.
42. Siomi, H., and Dreyfuss, G. (1995). A nuclear localization domain in the hnRNP A1 protein. J. Cell. Biol. 129, 551-560.
43. Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
44. Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P., and Strachan, T. (1992). Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635-636.
45. Ting, J.P., and Baldwin, A.S. (1993). Regulation of MHC gene expression. Curr. Opin. Immunol. 5, 8-16.
46. Touraine, J.L., and Betuel, H. (1981). Immunodeficiency diseases and expression of HLA antigens. Hum. Immunol. 2, 147-153.
47. Westerheide, S.D., Louis-Plence, P., Ping, D., He, X.F., and Boss, J.M. (1997). HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158, 4812-4821.
48. Yang, Z., Accolla, R.S., Pious, D., Zegers, B.J., and Strominger, J.L. (1988). Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. EMBO J. 7, 1965-1972.
49. Zhou, H., and Glimcher, L.H. (1995). Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2, 545-553.